Autophagy is a core molecular pathway for the preservation of cellular and organismal
homeostasis. Pharmacological and genetic interventions impairing autophagy responses …

Background Approximately 50% of melanomas harbor activating (V600) mutations in the
serine–threonine protein kinase B-RAF (BRAF). The oral BRAF inhibitor vemurafenib (PLX4032…

Immune checkpoint inhibitors 1 result in impressive clinical responses 2 , 3 , 4 , 5 , but
optimal results will require combination with each other 6 and other therapies. This raises …

Autophagy plays a key role in the maintenance of cellular homeostasis. In healthy cells,
such a homeostatic activity constitutes a robust barrier against malignant transformation. …

Despite the success of monotherapies based on blockade of programmed cell death 1 (PD-1)
in human melanoma, most patients do not experience durable clinical benefit. Pre-existing …

Autophagy is a lysosome-dependent degradative pathway frequently activated in tumor
cells treated with chemotherapy or radiation. Whether autophagy observed in treated cancer …

Exhausted CD8 + T (T ex ) cells in chronic infections and cancer have limited effector
function, high co-expression of inhibitory receptors and extensive transcriptional changes …

Therapeutic blocking of the PD1 pathway results in significant tumor responses, but
resistance is common. We demonstrate that prolonged interferon signaling orchestrates PDL1-…

The effect of the antidiabetic drug metformin on tumor growth was investigated using the
paired isogenic colon cancer cell lines HCT116 p53 +/+ and HCT116 p53 −/− . Treatment with …

Autophagy is an evolutionarily conserved, intracellular self-defense mechanism in which
organelles and proteins are sequestered into autophagic vesicles that are subsequently …